Open AccessTreatment of Chronic Hepatitis D Patients with Pegylated Interferon: A Real-World Experience
Author(s) -
Zaigham Abbas,
Mohammad Sadik Memon,
Hammad Mithani,
Wasim Jafri,
Saeed Hamid
Publication year - 2013
Publication title -
antiviral therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.747
H-Index - 87
eISSN - 2040-2058
pISSN - 1359-6535
DOI - 10.3851/imp2728
Subject(s) - medicine , gastroenterology , pegylated interferon , interferon , cirrhosis , chronic hepatitis , alanine transaminase , immunology , viral load , ribavirin , virus
Published experience of treating chronic hepatitis D patients with pegylated interferon (PEG-IFN)-α is limited. The aim of this study was to determine the efficacy of 48 weeks of treatment with PEG-IFN in naive patients outside the clinical trial setting, in the real world.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom